Pharmacokinetics and Safety/Tolerability Profiles of DA-2811 in Healthy Subjects

NCT04473417 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Forxiga
DRUG: DA-2811
DRUG: DA-2811
DRUG: DA-2811

Sponsor

Dong-A ST Co., Ltd.